Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Inhaled Hydrogen Gas in Healthy Volunteers
NCT04046211Phase 1Completed
- Sponsor
- Boston Children's Hospital
- Start
- Oct 2020
- Primary completion
- May 2021
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Molecular hydrogen in traumatic brain injury (TBI), ischemia, stroke and 2 more, sponsored by Boston Children's Hospital. Primary endpoint: Adverse Events. Started Oct 2020; status: completed.
02
Drugs
Molecular hydrogen
03
Conditions
traumatic brain injury (TBI)ischemiastrokecardiac arrest (SCA)myocardial infarction (MI)
Beyond the preview
Go deeper on NCT04046211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04046211.